Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Polycystic Ovary Syndrome × Contraception × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Metformin 6 Spironolactone 4 Progesterone 3 ganirelix 2 Pioglitazone 2 Ovidrel 2 Hydrocortisone 2 Estradiol 2 Cosyntropin 2 Thyrotropin 1 Testosterone 1 Ortho Evra 1 Methyltestosterone 1 Luteinizing Hormone 1 Leuprolide 1 Inositol 1 Flutamide 1 Dexamethasone 1 Contraception 1 Body Mass Index 1 Blood Urea Nitrogen 1 Adrenocorticotropic Hormone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01396369 2016-01-08

Flaxseed Lignan (Brevail)

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡